A New Paradigm in Cardiovascular Risk Reduction in Type 2 Diabetes

Learning Objectives: • Characterize type 2 diabetes as a cardiovascular risk factor • Outline key aspects of care for a patient with type 2 diabetes • Compare the classes of medications generally recommended for use in combination with metformin • Differentiate traditional clinical outcomes trials from cardiovascular safety trials • Describe the findings of cardiovascular safety t...
Primary Care Education Consortium

Diagnosis of Cirrhosis and Evaluation of Hepatic Encephalopathy: Common Errors and Their Significance for the PCP

LEARNING OBJECTIVES 1. Identify strategies to improve early detection of liver cirrhosis and its complications 2. Describe the evidence linking alterations in the human microbiome with liver disease and complications such as hepatic encephalopathy 3. Describe results of preliminary investigations showing improved health outcomes in patients with liver cirrhosis managed with treatments intende...
Primary Care Education Consortium

Role of the Microbiome in Disease: Implications for Treatment of Irritable Bowel Syndrome

LEARNING OBJECTIVES: 1. Describe the findings of the Human Microbiome Project and Gut Microbiome Initiative 2. Describe the evidence linking alterations in the human microbiome with disease, including irritable bowel syndrome 3. Describe results of treatments that act upon the gut microbiota in patients with irritable bowel syndrome TARGET AUDIENCE Family physicians and clinicians who wish ...
Primary Care Education Consortium

Sublingual Immunotherapy: A Guide for Primary Care

Journal Article Eligible for 1 AMA PRA Category 1 credit. Supplement to The Journal of Family Practice | Vol 66, No 4 | APRIL 2017 For CME credit, complete the article and go to www.pceconsortium.org/slit to complete the post-test survey. Allergen immunotherapy (AIT), the only potential diseasemodifying treatment for allergic disease, has been used for more than a century. Hankin et a...
Primary Care Education Consortium

The Cardiovascular Safety of Nonsteroidal Anti-Inflammatory Drugs: Putting the Evidence in Perspective

Enduring CME article for 1 AMA PRA Category 1 Credit Learning Objectives • Summarize the evidence and events that led the US Food and Drug Administration to require labeling changes regarding the safety of nonsteroidal anti-inflammatory drugs • Compare the effects of nonsteroidal anti-inflammatory drugs and aspirin on platelets • Summarize the evidence from clinical trials and registr...
Primary Care Education Consortium

YouTube Google+ Pinterest Twitter LinkedIn Facebook SlideShare
RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.